2012 Report Now Available!

Psoriasis is a chronic skin disease that is the most prevalent autoimmune disease in the U.S. with as many as 7.5 million Americans affected (2.5% of the population). Psoriasis Market Info™ from Drug Market Info captures all of the relevant data on this disease and its management. The market is currently valued at $2+ billion and is expected to grow significantly in the future, largely due to the unpredictable and chronic nature of the disease and a high unmet treatment need. The uptake of biologics, the emergence of therapies that act on different disease targets, and the continued need for topical therapies will make this market attractive for any new therapy that is effective and safe.

Treatments for Psoriasis cover the spectrum topical (mostly topical steroids), phototherapy, systemics and biologics. These therapies can be used as monotherapy, in combination, or on a rotational or sequential basis. Psoriasis Market Info™ covers all of these therapies and reports on these modalities with details about each product, as well as the Leading Companies and Brands.

One of the key issues in this market is the impact of psoriasis on the lives of patients, 60% of whom report the disease to be a large problem in everyday life. For this reason, assessment of the psoriasis market is incomplete without an understanding of the Patient Perspective. Actual patient verbatims are included in all Drug Market Info reports. This critical patient input is provided throughout Psoriasis Market Info™, which is just one of its unique benefits.

Other benefits of Psoriasis Market Info™ you won’t find in other reports include…

• A presentation-ready format: 
  The report is presented entirely on PowerPoint slides to make reading and data assimilation easier, quicker and ready to cut and paste into your own reports/presentations
• Five years of sales and prescription data:
  Pharmaceutical audit data provides an estimate of the actual market value, along with growth trends and analyses by therapeutic modality as well as by brand
• Thought Leader Review:
  All Drug Market Info reports are reviewed by and incorporate the insights of a leading thought leader in the field to ensure clinical accuracy and relevancy from a doctor’s perspective

This Report Includes...

• 88 customizable slides

• 61 graphs and charts

• Photographs of the disease and actual psoriasis patients

• Quotes from psoriasis patients

Click for table of contents and list of charts and graphs

Contents

• Section 1: Patients Understanding Psoriasis: Focuses on patients and how they feel about their disease. Includes basic disease information, psoriasis description, as well as epidemiology.

• Section 2: Perspectives Psoriasis Management: A review of therapies, advantages and disadvantages, listing of major products and companies. Includes patient experience and insights on various therapies.

• Section 3: Potential Psoriasis Market: Overall sales and prescription volume, growth rates and key products and companies provided. Includes pipeline products and market attractiveness assessment.

• Summary: The major take-aways from the presentation, including "What Makes the Psoriasis Market Attractive," "Five Most Important Facts About Psoriasis," "Patient Insights" and a statement from the National Psoriasis Foundation (NPF).

I do think about the day...where I won't have to give it [psoriasis] a second thought. Because I know that there are medications and I'm doing the treatments to keep me in remission and I won't have to ever worry about it again. I do think about that day. And I really wish that day was here. I wish it was awhile ago.

Patient perspective from slide #77       

It’s as easy as 1, 2, 3 with Psoriasis Market Info. Insights on patients, doctors, treatment and market value are presented in an easy-to-follow format with current, reliable, referenced data.

As many as 7.5 million Americans are affected by psoriasis. Although many patients have mild disease, a significant number have severe disease that negatively impacts their quality of life. Learn more about psoriasis patients, the different types of psoriasis and how many patients are diagnosed.

The treatment approach for psoriasis is a stepped approach that depends on the severity of the disease and body areas involved. The therapies utilized include topical, phototherapy, sytemics and biologics, many of which are used in combination. Learn more about goals of therapy and the individual treatments and how they are used by patients.

The overall value of the Psoriasis market in 2010 was $1.8+ billion and continues to grow as more high-priced biologics enter the market. Some of the key players with psoriasis therapies are Amgen, Centocor, Abbott and Leo Pharma. Stelara (ustekinumab) was recently launched by Centocor (Johnson & Johnson) and was eagerly anticipated by dermatologists. Learn more about the specific products used, prescription volume, pricing and pipeline products.

The Market Attractiveness Rating for the Psoriasis market is HIGH as determined by Drug Market Info. This unique rating summarizes all of the key points about this market in one easy slide to let you see what is needed and where a potential new therapy may fit. In addition, Drug Market Info summarizes the five most important facts you need to know about this market.

Download 2012 Report: $4,950.00

Download 2011 Report: $3,950.00 – Save $1,000

Buy together with Psoriatic Arthritis Market Info and save $1,000!